Imagawa H, Nagar SP, Montgomery W, Nakamura T, Sato M, Davis KL. Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine. Neuropsychiatr Dis Treat. 2018 Feb 22;14:611-21. doi: 10.2147/NDT.S150261
Nagar SP, Sato M, Montgomery W, Nakamura T, Imagawa H, Davis KL. Treatment patterns and characteristics of adult patients with attention deficit/hyperactivity disorder receiving atomoxetine in Japan. Poster presented at the 2017 ISPOR 22nd Annual International Meeting; May 23, 2017. Boston, MA. [abstract] Value Health. 2017 May; 20(5):A305.
Meyers J, Grebla R, Ajmera M, Davis K, Pawaskar M. Comorbidity burden in delayed and nondelayed ADHD diagnosis among commercially insured adults in the United States. Poster presented at the 28th Annual US Psychiatric and Mental Health Congress; September 10, 2015. San Diego, CA.
Hodgkins P, Setyawan J, Mitra D, Davis K, Quintero J, Fridman M, Shaw M, Harpin V. Management of adhd in children across europe: patient demographics, physician characteristics and treatment patterns. Eur J Pediatr. 2013 Feb 1;172(7):895-906.
Sasane R, Mitra D, Hodgkins P, Davis KL. Childhood ADHD in Europe: a comparison of patient and physician profiles across countries. Poster presented at the 23rd ECNP Congress; August 2010. [abstract] Eur Neuropsychopharmacol. 2010 Aug; 20(Suppl. 3):S616-7.
Mitra D, Sasane R, Hodgkins P, Davis KL. Management of ADHD among children in Europe: a comparison of practice patterns across countries. Poster presented at the 23rd ECNP Congress; August 2010. [abstract] Eur Neuropsychopharmacol. 2010 Aug; 20(Suppl. 3):S625-6.
Jackel J, Davis KL, Candrilli SD. Trends in rates of pediatric bipolar disorder-related hospitalizations and related resource use in the United States. Poster presented at the 2009 ISPOR 12th Annual European Congress; October 2009. Paris, France.
Davis KL, Manjunath R, Ettinger AB. The association between attention deficit and psychiatric disorders and adherence to antiepileptic drug treatment in pediatric epilepsy. Poster presented at the 62nd Annual Meeting of the American Epilepsy Society; December 2008.
Bray JW, Zarkin GA, Davis KL, Mitra D, Higgins-Biddle JC, Babor TF. The effect of screening and brief intervention for risky drinking on health care utilization in managed care organizations. Med Care. 2007 Feb 28;45(2):177-82.
Bray JW, Davis KL, Graver L, Schroeder D, Buck JA, Dilonardo J, Vandivort R. Mental health and substance abuse treatment utilization among individuals served by multiple public agencies in 3 states. J Behav Health Serv Res. 2005 Jan 1;32(3):282-93.
Bartosch WJ, Bray JW, Davis KL, Graver L, Schroeder D, Miller K. Variations in mental health and substance abuse service provider types between medicaid and state agencies in three states. Presented at the 132nd Annual Meeting of the American Public Health Association; November 2004.
Zarkin GA, Bray JW, Davis KL, Babor TF, Higgins-Biddle JC. The costs of screening and brief intervention for risky alcohol use. J Stud Alcohol. 2003 Jan 1;64(6):849-57.